CHICAGO, IL USA (UroToday.com) - Presented by Pieczonka CM,1 Concepcion RS,2 Tutrone RF,3 Penson DF,4 Bailen JL,5 Olsson CA,6 Forrest JB,7 Kassabian V,8 Mehlhaff BA,9 Shore ND,11 Lance RS,11 Tyler RC,12 Sandler A,12 McCoy C,12 Whitmore JB,12 and Cooperberg MR13 at the American Society of Clinical Oncology (ASCO) 50th Annual Meeting - May 30 - June 3, 2014 - Chicago, Illinois USA
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Click HERE to listen to an interview with Christopher Pieczonka, MD, one of the authors of the study
1Associated Medical Professionals, Syracuse, NY, USA; 2Urology Associates, P.C., Nashville, TN, USA; 3Chesapeake Urology Research Associates, Baltimore, MD, USA; 4Vanderbilt-Ingram Cancer Center, Nashville, TN, USA; 5First Urology Clinical Research, Jeffersonville, IN, USA; 6Integrated Medical Professionals, Columbia University Medical Center, North Hills, NY, USA; 7Urologic Specialists of Oklahoma, Inc., Tulsa, OK, USA; 8Georgia Urology, Atlanta, GA, USA; 9Oregon Urology Institute, Springfield, OR, USA; 10Carolina Urologic Research Center, Myrtle Beach, SC, USA; 11Urology of Virginia, Norfolk, VA, USA; 12Dendreon Corporation, Seattle, WA, USA; 13University of California San Francisco, San Francisco, CA, USA